Publication | Closed Access

STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds

ImmunogeneticsAllergyAutoimmune DiseaseStat3 Gain-of-function MutationsAutoantibody ProductionImmunologyCell DeathAutoimmunityImmunologic DiseaseImmunotherapyMedicineAutoimmune Lymphoproliferative SyndromeBh3 Mimetic Compounds